What Is Familial Hypercholesterolemia, and Why Does It Matter?
- 1 June 2020
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 141 (22) , 1760-1763
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus PanelEuropean Heart Journal, 2017
- Genetic identification of familial hypercholesterolemia within a single U.S. health care systemScience, 2016
- Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained ClinicallyArteriosclerosis, Thrombosis, and Vascular Biology, 2016
- Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe HypercholesterolemiaJACC, 2016
- Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217European Heart Journal, 2016
- Aligning Policy to Promote Cascade Genetic Screening for Prevention and Early Diagnosis of Heritable DiseasesJournal of Genetic Counseling, 2015
- The LDL ReceptorArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Diagnosing familial hypercholesterolaemia: the relevance of genetic testingEuropean Heart Journal, 2006
- Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular geneticsThe American Journal of Cardiology, 1993
- Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group.BMJ, 1991